Breakthrough mouse produced with both lesions associated with Alzheimer's

August 23, 2001

JACKSONVILLE, Fla., - Researchers at Mayo Clinic in Jacksonville, Fla., have successfully bred mice exhibiting amyloid plaques and neurofibrillary tangles, the two key pathologic hallmarks of Alzheimer's disease (AD). Until now, an animal model that exhibited both of these brain lesions did not exist.

The breakthrough is expected to provide investigators a better animal model in which to test therapies aimed at preventing or halting progression of the degenerative brain disease affecting approximately 4 million Americans. The Mayo Clinic team of Michael Hutton, Ph.D.; Dennis Dickson, M.D.; Jada Lewis, Ph.D.; Shu-Hui Yen, Ph.D.; and Eileen McGowan, Ph.D., will publish its work in the August 24 issue of Science.

Many researchers studying potential causes of AD suspect that when amyloid beta protein deposits in the brain to form plaques, the phenomenon sets off a cascade of pathology that leads to AD. Somewhere in the disease process neurofibrillary tangles, caused by abnormal tau protein, develop in the brain, and brain cells die as well. No one has proven whether the plaques lead to tangles or vice versa.

The Mayo group bred a mouse they genetically engineered to develop neurofibrillary tangles with a mouse similarly engineered to develop amyloid plaques. Hutton believes the resulting double transgenic mouse strengthens the amyloid cascade hypothesis. "The evidence we've got is consistent with that," Hutton says. "What we saw in the crossbred mice were not only plaques and tangles, but the tangle pathology was enhanced in regions where the plaques occurred." And he says the lesions occurred in regions of the brain first affected by AD. "If we were simply seeing random changes in tangle pathology in areas that weren't related to amyloid or Alzheimer's disease, this would not be so interesting," Hutton says. "The key point is we see the enhanced tangle pathology in areas that are affected in Alzheimer's."

The Hutton team's double transgenic mouse will provide researchers a more complete model of human AD. Hutton says biochemical changes in tau that occur in humans with the disease also occur in these mice.

Researchers at Mayo have now begun to test the recently developed amyloid vaccine on their double transgenic mice to see if the vaccine prevents tangle formation and brain cell death.

They also hope to breed an even better AD mouse model by using mice that deposit amyloid earlier in their lifespan than the animals they are currently breeding. "One of the biggest problems we have is that the tau mice don't live all that long," Hutton says. "They start to die at an age when the pathology in the amyloid mice hasn't reached its final stage. We're in the process of trying to get mice that deposit amyloid more rapidly. This will basically let us compress the time frame of these studies, allowing us to look at mice that have lots of amyloid together with tau pathology, and to do it all within the lifespan of these crossed animals."

Mayo Clinic, Jacksonville

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to